Drugs News and Research

RSS

New drug to stop cancer cells from growing and to stimulate immune system to destroy cancer cells found

A study conducted at Scott & White Healthcare in Temple, Texas, found that a new drug stopped the growth of breast tumors in mice. This drug is unique in that it works both by stopping the cancer cells from growing and metastasizing to other organs, and by stimulating the immune system to destroy breast cancer cells and keeps them from coming back.

23 Dec 2009

Back pain problems continue to rise in U.S.

The Bonati Spine Institute, the leader in minimally invasive laser spine surgery, reports the results of studies that Americans are increasingly reporting back pain and spending more on back pain, but cautions consumers to carefully research the experience and the surgical outcome results when choosing their spine team.

23 Dec 2009

High prevalence of type 2 diabetes may be linked to excess niacin intake

Facing the increasing prevalence of type 2 diabetes worldwide in the past few decades, one may ask what is wrong with humans. Geneticists tell us that the human genome has not changed markedly in such a short time.

23 Dec 2009

New project analyzes genetic sequence and variations of every gene expressed by 1,000 tumors

No two tumors are alike, but analyzing the genetics of cancers from different parts of the body may reveal surprising details useful for treatment and prevention.

22 Dec 2009

Use of digital checklist for patients during pandemic reduces fatigue factor, shows report

The use of a digital checklist for patients being administered emergency drugs during a pandemic or following a biological terrorist attack reduces the fatigue factor, according to a report in the International Journal of Healthcare Technology and Management, and could save lives.

22 Dec 2009

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures

To identify the hemophilia mutation that affected Queen Victoria and her European relatives, scientific detectives used a cutting-edge "deep sequencing tool." Able to trace rare genetic disease mutations, the tool can turn a single laboratory into a fertile genetic research center.

22 Dec 2009

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising.

22 Dec 2009

MSF report names malnutrition, inadequate funds for HIV/AIDS, neglected diseases among top humanitarian crises of 2009

Inadequate international funding for HIV/AIDS and neglected diseases as well as global malnutrition were among the top 10 humanitarian crises outlined in an annual report issued Monday by Medecins Sans Frontieres, the Associated Press reports (Astor, 12/21).

22 Dec 2009

Today's opinions and editorials

'Twill be the night before Christmas when the Senate delivers the top item on White House Chief of Staff Rahm Emanuel's wish list: a health-care bill (William McGurn, 12/21).

22 Dec 2009

Effectiveness of Genfit’s GFT505 clinical drug candidate questioned

It has come to the attention of Genfit, a leading biotech company listed on Alternext, that an undisclosed group of so-called “well known scientific experts” have issued a press release, via a news wire, purporting to put into question the effectiveness of Genfit’s main clinical drug candidate GFT 505.

22 Dec 2009

Prescription medication at lower costs for Oregon state agency employees

Public employees in the state of Oregon will soon have access to a wider range of prescription medication at lower costs.

22 Dec 2009

Genome-wide study of African and African-American ancestry released by scientists

People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.

22 Dec 2009

Web-based CME courses to educate physicians on drug industry offered by FSMB Foundation

A new web-based Continuing Medical Education (CME) initiative by the Federation of State Medical Boards Foundation is seeking to educate physicians on various aspects of the relationship between the medical community and the pharmaceutical industry.

22 Dec 2009

Cell Therapeutics supports Code on Interactions with Healthcare Professionals

Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.

22 Dec 2009

Rifampicin resistant tuberculosis

Scientists have identified a strain of antibiotic-resistant tuberculosis that thrives in the presence of rifampin, a front-line drug in the treatment of tuberculosis. The bacterium was identified in a patient in China and is described in a study by researchers at the Johns Hopkins Bloomberg School of Public Health, Chongqing Pulmonary Hospital, Lanzhou University and Fudan University.

22 Dec 2009

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the Company and Oceana Therapeutics have agreed to jointly prepare for a meeting with the U.S. Food & Drug Administration regarding the continued development of URG101.

22 Dec 2009

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

22 Dec 2009

Clarient announces acquisition of Applied Genomics

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has acquired privately held, Huntsville, AL-based Applied Genomics, Inc. (AGI) in an all-stock merger valued at up to $17.6 million, if all conditions and milestones set forth in the merger agreement are successfully met.

21 Dec 2009

Response Biomedical receives USPTO Notice of Allowance for its “Sensitive Immunochromatographic Assay”

Response Biomedical Corporation announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a continuation of the patent entitled “Sensitive Immunochromatographic Assay”. This patent covers key aspects of Response Biomedical’s lateral flow immunoassays with the proprietary RAMP® testing platform.

21 Dec 2009

OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries

Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.

21 Dec 2009

Drugs News and Research

New drug to stop cancer cells from growing and to stimulate immune system to destroy cancer cells found

Back pain problems continue to rise in U.S.

High prevalence of type 2 diabetes may be linked to excess niacin intake

New project analyzes genetic sequence and variations of every gene expressed by 1,000 tumors

Use of digital checklist for patients during pandemic reduces fatigue factor, shows report

Tel Aviv University's new Genome Analyzer fuels research dreams and tomorrow's cures

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

MSF report names malnutrition, inadequate funds for HIV/AIDS, neglected diseases among top humanitarian crises of 2009

Today's opinions and editorials

Effectiveness of Genfit’s GFT505 clinical drug candidate questioned

Prescription medication at lower costs for Oregon state agency employees

Genome-wide study of African and African-American ancestry released by scientists

Web-based CME courses to educate physicians on drug industry offered by FSMB Foundation

Cell Therapeutics supports Code on Interactions with Healthcare Professionals

Rifampicin resistant tuberculosis

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Findings may help develop new antiviral drugs for influenza

Clarient announces acquisition of Applied Genomics

Response Biomedical receives USPTO Notice of Allowance for its “Sensitive Immunochromatographic Assay”

OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News